Warning:
This document is being maintained for historical purposes, but is now out of date. To view current guidelines please visit:
- STD Treatment Guidelines at http://www.cdc.gov/STD/treatment
1993 Sexually Transmitted Diseases Treatment Guidelines
09/24/1993 SUGGESTED CITATION Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR 1993;42(No. RR-14): {inclusive page numbers}. CIO Responsible for this publication: National Center for Prevention Services, Division of Sexually Transmitted Diseases and HIV Prevention Ophthalmia Neonatorum Prophylaxis Instillation of a prophylactic agent into the eyes of all newborn infants is recommended to prevent gonococcal ophthalmia neonatorum and is required by law in most states. Although all the regimens that follow effectively prevent gonococcal eye disease, their efficacy in preventing chlamydial eye disease is not clear. Furthermore, they do not eliminate nasopharyngeal colonization with C. trachomatis. Treatment of gonococcal and chlamydial infections among pregnant women is the best method for preventing neonatal gonococcal and chlamydial disease. However, ocular prophylaxis should continue because it can prevent gonococcal ophthalmia and, in some populations, greater than 10% of pregnant women may receive no prenatal care. Prophylaxis - Recommended Preparations - Silver nitrate (1%) aqueous solution in a single application or Erythromycin (0.5%) ophthalmic ointment in a single application or Tetracycline ophthalmic ointment (1%) in a single application. One of the above preparations should be instilled into the eyes of every neonate as soon as possible after delivery. If prophylaxis is delayed (i.e., not administered in the delivery room), hospitals should establish a monitoring system to see that all infants receive prophylaxis. All infants should be administered ocular prophylaxis, whether delivery is vaginal or caesarian. Single-use tubes or ampules are preferable to multiple-use tubes. Bacitracin is not effective.
This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.